Spruce Biosciences Inc (SPRB) support and resistance · rev $4.9M
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
This page maps Spruce Biosciences Inc (SPRB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
SPRB currently screens at market cap $3.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SPRB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SPRB quote page for the session range and the stock page for the full model.
Not investment advice.